Naftopidil


Concise Prescribing Info
Indications/Uses
Benign prostatic hyperplasia.
Dosage/Direction for Use
Adult : PO 25-75 mg/day.
Dosage Details
Oral
Benign prostatic hyperplasia
Adult: 25-75 mg daily.
Special Precautions
Not intended for use in women.
Adverse Reactions
Intraoperative floppy iris syndrome, ejaculatory disorders, buzzing or lightheadedness, hypotension.
Action
Description: Naftopidil is a peripheral α1-adrenergic receptor antagonist used to treat lower urinary tract symptoms.
Pharmacokinetics:
Metabolism: Undergoes hepatic metabolism by CYP2C9 and CYP3A4 isoenzymes.
Excretion: Via bile.
Disclaimer: This information is independently developed by MIMS based on Naftopidil from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in